Astrazeneca (AZN) Return on Assets (2016 - 2025)

Historic Return on Assets for Astrazeneca (AZN) over the last 17 years, with Q4 2025 value amounting to 0.11%.

Astrazeneca's Return on Assets rose 300.0% to 0.11% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.11%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.11% for FY2025, which is 300.0% up from last year.
Per Astrazeneca's latest filing, its Return on Assets stood at 0.11% for Q4 2025, which was up 300.0% from 0.1% recorded in Q3 2025.
Astrazeneca's Return on Assets' 5-year high stood at 0.11% during Q4 2025, with a 5-year trough of 0.03% in Q1 2022.
In the last 5 years, Astrazeneca's Return on Assets had a median value of 0.07% in 2023 and averaged 0.05%.
In the last 5 years, Astrazeneca's Return on Assets plummeted by -1000bps in 2022 and then soared by 800bps in 2023.
Quarter analysis of 5 years shows Astrazeneca's Return on Assets stood at 0.0% in 2021, then soared by 631bps to 0.03% in 2022, then surged by 167bps to 0.07% in 2023, then grew by 19bps to 0.08% in 2024, then soared by 30bps to 0.11% in 2025.
Its Return on Assets stands at 0.11% for Q4 2025, versus 0.1% for Q3 2025 and 0.09% for Q2 2025.

Peer Comparison